BioCardia Inc. (BCDA)
NASDAQ: BCDA
· Real-Time Price · USD
2.14
-0.09 (-4.04%)
At close: Jun 27, 2025, 3:59 PM
2.15
0.47%
After-hours: Jun 27, 2025, 04:01 PM EDT
BioCardia Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| Collaboration Agreement Revenue | 477K | 1.35M |
| Collaboration Agreement Revenue Growth | -64.64% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.2M | 906K | 2.77M | 746K | 1.09M | 941K | 1.08M | 1.18M | 1.19M | 924K | 1.13M | 1.17M | 1.2M | 1.43M | 1.29M | 1.2M | 1.18M | 1.22M | 1.41M | 1.38M | 1.72M | 1.54M | 1.39M | 1.44M | 1.63M | 1.44M | 1.28M | 1.32M | 1.71M | 1.69M | 1.32M | 1.58M | 1.8M | 3.59M | 379K | 68K | 68K | 46K | 38K | 53K | 61K |
| Selling, General, and Administrative Revenue Growth | +32.01% | -67.25% | +270.78% | -31.50% | +15.73% | -13.11% | -8.30% | -0.76% | +28.79% | -18.09% | -3.26% | -2.91% | -15.72% | +10.55% | +7.78% | +1.61% | -3.45% | -13.42% | +2.25% | -19.80% | +11.28% | +11.01% | -3.34% | -11.83% | +13.11% | +12.39% | -3.17% | -22.38% | +1.19% | +27.61% | -16.43% | -12.31% | -49.79% | +848.02% | +457.35% | 0.00% | +47.83% | +21.05% | -28.30% | -13.11% | n/a |
| Research and Development Revenue | 1.53M | 1.42M | 931K | 800K | 1.24M | 1.16M | 1.87M | 2.31M | 2.38M | 2.2M | 2.14M | 2.3M | 2.19M | 2.12M | 2.24M | 2.36M | 1.84M | 2.33M | 2.47M | 2.22M | 2.79M | 2.17M | 2.01M | 2.22M | 2.17M | 2.21M | 2.26M | 2.03M | 1.96M | 1.77M | 1.7M | 1.29M | 1.03M | 1.71M | 684K | 497K | 441K | 218K | 432K | 475K | 393K |
| Research and Development Revenue Growth | +8.13% | +51.99% | +16.38% | -35.54% | +7.35% | -38.25% | -19.10% | -2.94% | +8.36% | +2.61% | -6.94% | +5.40% | +3.36% | -5.58% | -5.17% | +28.30% | -20.82% | -6.02% | +11.24% | -20.17% | +28.39% | +8.12% | -9.55% | +2.45% | -1.77% | -2.52% | +11.37% | +3.89% | +10.39% | +4.18% | +31.27% | +25.36% | -39.52% | +149.71% | +37.63% | +12.70% | +102.29% | -49.54% | -9.05% | +20.87% | n/a |